IIS Program
Investigator Initiated Studies (IIS) play a key role in answering important scientific questions. Such studies also enhance the understanding of our products and their appropriate application, and can initiate new ideas for further research. An Investigator Initiated Study (IIS) is clinical research that is conceived, designed, initiated, conducted, analyzed and reported by an investigator who is not an employee or agent of Biocartis. The IIS researcher can request Biocartis support via funding, material, service and/or training.
Responsibilities of the IIS applicant include:
- Study design and conduct
- Obtaining the patient consent, ethics committee and/or regulatory authority approvals, as required
- Compliance with local laws, regulations and guidelines
- Data analysis and interpretation
- Publication
- Submitting intermediate updates and final report to Biocartis Scientific Experts
Areas of interest
Molecular biology, Oncology and Infectious Disease
IIS application process
This procedure contains the application process for an IIS grant request by investigator and the review and approval/decline decision of IIS research by Biocartis. A Scientific Review Committee (SRC) is responsible for reviewing all IIS applications. SRC members will scrutinize the IIS applications using the following acceptance criteria:
- Alignment with corporate and scientific goals and objectives as outlined in the annual needs assessment
- Strength of study
- Study feasibility assessment
- Investigator credentials
- Type and amount of research grant requested
Each application will be discussed on its merits. The SRC will respond to the application with either an approval, decline or request for additional information within 14 working days.
How to submit
The applicant fills in a fully completed IIS application form and sends it via email to [email protected]. The IIS application form can be downloaded here.